Thromboelastographic Results and Hypercoagulability Syndrome in Patients With Coronavirus Disease 2019 Who Are Critically Ill

Jared Robert Mortus; Stephen E Manek; Lisa Suzanne Brubaker; Michele Loor; Miguel Angel Cruz; Barbara W Trautner; Todd K Rosengart

doi:10.1001/jamanetworkopen.2020.11192

Thromboelastographic Results and Hypercoagulability Syndrome in Patients With Coronavirus Disease 2019 Who Are Critically Ill

JAMA Netw Open. 2020 Jun 1;3(6):e2011192. doi: 10.1001/jamanetworkopen.2020.11192.

Authors

Jared Robert Mortus¹, Stephen E Manek¹, Lisa Suzanne Brubaker^{1

2}, Michele Loor¹, Miguel Angel Cruz^{2

3}, Barbara W Trautner^{4

5}, Todd K Rosengart¹

Affiliations

¹ Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.
² Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey VA Medical Center, Houston, Texas.
³ Department of Medicine, Baylor College of Medicine, Houston, Texas.
⁴ Center for Innovations in Quality, Effectiveness, and Safety, Michael E. DeBakey VA Medical Center, Houston, Texas.
⁵ Section of Health Services Research, Departments of Medicine and Surgery, Baylor College of Medicine, Houston, Texas.

Abstract

This cohort study examines the association of thromboelastographic results with hypercoagulability among patients with coronavirus disease 2019 who have been admitted to an intensive care unit.

MeSH terms

Aged
Aged, 80 and over
Betacoronavirus
COVID-19
Coronavirus
Coronavirus Infections / complications*
Coronavirus Infections / virology
Critical Illness*
Female
Humans
Intensive Care Units
Male
Middle Aged
Pandemics
Pneumonia, Viral / complications*
Pneumonia, Viral / virology
SARS-CoV-2
Thrombelastography / methods
Thrombophilia / complications*
Thrombosis

Grants and funding

T32 HL139425/HL/NHLBI NIH HHS/United States